Silver Book

Silver Book Fact

From approval in 2011 through 2015 >54,000 TAVRs were performed in 418 centers in 48 states

Fact image

Grover F, Vemalapalli S, Carroll J, Edwards F, et al. 2016 Annual Report of The Society for Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry. Ann Thorac Surg. 2017; 103(3). http://www.sciencedirect.com/science/article/pii/S0003497516317659

Reference

Title
2016 Annual Report of The Society for Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry
Publication
Ann Thorac Surg
Publication Date
2017
Authors
Grover F, Vemalapalli S, Carroll J, Edwards F, et al.
Volume & Issue
Volume 103, Issue 3
Pages
102-35
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Publications

Silver Book: Valve Disease Fact Sheet

 https://www.silverbook.org/wp-content/uploads/2018/02/SB-TN.jpg Thumbnail

Related Facts

  • Cost-effectiveness of TAVR in sSAS patients
    Patients with severe symptomatic aortic stenosis (sSAS) considered to be at high surgical risk who underwent transcatheter aortic valve replacement (TAVR) experienced lifetime incremental cost-effectiveness ratios of $55,090 per QALY…  
  • Undertreatment of patients with sSAS
    AS is often undertreated — one study found that 56% of severe symptomatic aortic stenosis (sSAS) patients referred to a cardiothoracic surgeon were not operated on.  
  • From approval in 2011 through 2015 >54,000 TAVRs were performed in 418 centers in 48 states
     
  • Surgical Aortic Valve Replacements in 2010
    In 2010, ~67,500 surgical aortic valve replacements (SAVR) were performed in the U.S.  
  • TAVR v. SAVR in Intermediate-Risk SAS Patients
    At 1-year, severe aortic stenosis (SAS) patients with intermediate surgical mortality risk who underwent transcatheter aortic valve replacement (TAVR), had all-cause mortality rates of 7.4% (compared to 13% for surgical…